(Q44130666)

30 November 2017

The effects of levetiracetam on objective and subjective sleep parameters in healthy volunteers and patients with partial epilepsy (English)

1 reference

30 November 2017

1 reference

Caroline Bell

1

1 reference

30 November 2017

Hilde Vanderlinden

2

1 reference

30 November 2017

Reinhard Hiersemenzel

3

1 reference

30 November 2017

Christian Otoul

4

1 reference

30 November 2017

David Nutt

5

1 reference

30 November 2017

Sue Wilson

6

1 reference

30 November 2017

1 September 2002

1 reference

Journal of Sleep Research

30 November 2017

1 reference

30 November 2017

11

1 reference

30 November 2017

3

1 reference

30 November 2017

255-263

1 reference

A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy.

30 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2869.2002.00301.X

Revisiting the concept of identifiable neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2869.2002.00301.X

Outpatient sleep recording during antiepileptic drug monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2869.2002.00301.X

The effects of lamotrigine on sleep in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2869.2002.00301.X

The influence of carbamazepine on sleep-EEG and the clonidine test in healthy subjects: results of a preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2869.2002.00301.X

The two-period cross-over clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2869.2002.00301.X

Self-reported sleep disorder symptoms in epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2869.2002.00301.X

The analysis of data from 2 x 2 cross-over trials with baseline measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2869.2002.00301.X

Sleep patterns in patients with late onset partial epilepsy receiving chronic carbamazepine (CBZ) therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2869.2002.00301.X

Therapeutic safety monitoring: what to look for and when to look for it.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2869.2002.00301.X

The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2869.2002.00301.X

Effects of lamotrigine on nocturnal sleep, daytime somnolence and cognitive functions in focal epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2869.2002.00301.X

Lamotrigine associated with insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2869.2002.00301.X

Effects of carbamazepine on sleep in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2869.2002.00301.X

Levetiracetam does not modulate neuronal voltage-gated Na+ and T-type Ca2+ currents

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2869.2002.00301.X

10.1046/J.1365-2869.2002.00301.X

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference